GGrantIndex
Sort

46,585 grants matching heart failure

Dzip1 and Mitral Valve Prolapse

$499,263
Russell Norris · Medical University Of South Carolina · R01 · FY2021 · HL

Dzip1 and Mitral Valve Prolapse

$499,263
Russell Norris · Medical University Of South Carolina · R01 · FY2023 · HL

Building Interdisciplinary Research Careers in Women's Health

$499,249
Judith G Regensteiner · University Of Colorado Denver · K12 · FY2008 · HD

The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community

$499,244
Christopher M O'Connor · Inova Health Care Services · R18 · FY2021 · FD

Chemical-based membrane sealants for dystrophic muscle

$499,232
Joseph Mark Metzger · University Of Minnesota · R01 · FY2009 · HL

Stem cells and the fibroblast/adipocyte lineage in arrhythmogenic cardiomyopathy

$499,229
Karen L Vikstrom · University Of Michigan At Ann Arbor · RC1 · FY2010 · HL

Biomarkers of Sudden Death and Progressive Heart Failure

$499,219
Gordon Frank Tomaselli · Johns Hopkins University · RC1 · FY2010 · HL

Autoimmune Determinants of Human Cardiac Myosin

$499,215
Madeleine W. Cunningham · University Of Oklahoma Hlth Sciences Ctr · R56 · FY2008 · HL

Optimizing Chronic Disease Prevention and Management in Advanced Dementia

$499,209
Jennifer Tjia · Univ Of Massachusetts Med Sch Worcester · R21 · FY2010 · HS

Transcriptional regulation of cardiac morphogenesis

$499,141
Anthony B. Firulli · Indiana University Indianapolis · P01 · FY2020 · HL

Transcriptional regulation of cardiac morphogenesis

$499,141
Anthony B. Firulli · Indiana University Indianapolis · P01 · FY2019 · HL

Transcriptional regulation of cardiac morphogenesis

$499,139
Anthony B. Firulli · Indiana University Indianapolis · P01 · FY2021 · HL

Genetic Metabolic Myopathy - Acid Maltase Deficiency

$499,136
Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR

Reactive Oxygen Species and Respiratory Muscle Dysfunction in Heart Failure

$499,106
Leonardo Ferreira · Duke University · R01 · FY2025 · HL

Advancing Commercial Readiness of a No-implant Interatrial Shunt Therapy to Treat Heart Failure

$499,103
Thomas Diffley Pate · Alleviant Medical, Inc. · SB1 · FY2024 · HL

Impact of Emerging Health Insurance Designs on Diabetes Complications

$499,040
James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2015 · DK

Patient-Centered Approach to Advance Care Planning

$498,959
Karin T Kirchhoff · University Of Wisconsin-Madison · R01 · FY2006 · HS

Improving Self-Care of Informal Caregivers of Adults with Heart Failure

$498,949
Barbara J Riegel · University Of Pennsylvania · R01 · FY2023 · NR

PROJECT 3

$498,934
Daniel A Beard · Medical College Of Wisconsin · P50 · FY2013 · GM

New anti-complement therapy to reduce reperfusion injury: Phase II

$498,890
Claudio Maldonado · Endoprotech, Inc. · R42 · FY2008 · HL

MicroRNA as mediators of angiogenesis & ischemic myocardial repair

$498,846
Meifeng Xu · University Of Cincinnati · R01 · FY2016 · HL

Novel cardioskeletal myopathy associated with MYL2

$498,844
Danuta Szczesna-Cordary · University Of Miami School Of Medicine · R01 · FY2017 · HL

Novel cardioskeletal myopathy associated with MYL2

$498,844
Danuta Szczesna-Cordary · University Of Miami School Of Medicine · R01 · FY2018 · HL

Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair

$498,828
Yao Liang Tang · Augusta University · R01 · FY2024 · HL

Innate allorecognition and KIR/LILR/HLA associations in kidney transplantation

$498,760
Fadi G. Lakkis · Stanford University · U01 · FY2025 · AI